Skip to Main Content
Table 3—

Relation of the metabolic syndrome, the individual components (according to the Adult Treatment Panel III criteria), and the presence of coronary collaterals

CrudeAdjusted for age and sexAdjusted for age, sex, and severity of coronary artery disease*
Metabolic syndrome 1.3 (0.7–2.1) 1.3 (0.8–2.3) 1.2 (0.7–2.0) 
Number of components    
    Zero Reference Reference Reference 
    One 0.9 (0.3–3.2) 0.9 (0.3–3.1) 1.1 (0.3–4.1) 
    Two 1.0 (0.3–3.5) 1.0 (0.3–3.5) 1.2 (0.3–4.1) 
    Three 1.4 (0.4–4.7) 1.4 (0.4–4.8) 1.5 (0.4–5.3) 
    Four 1.3 (0.4–4.8) 1.4 (0.4–5.1) 1.3 (0.3–4.9) 
    Five 0.9 (0.2–3.7) 1.0 (0.2–4.0) 1.0 (0.2–4.3) 
Individual components    
    Waist circumference (cm) 1.02 (0.99–1.06) 1.02 (0.99–1.06) 1.02 (0.98–1.06) 
    Systolic blood pressure (mmHg) 0.99 (0.98–1.01) 0.99 (0.97–1.01) 0.99 (0.97–1.01) 
    Diastolic blood pressure (mmHg) 0.98 (0.94–1.01) 0.98 (0.94–1.01) 0.98 (0.94–1.01) 
    HDL cholesterol (mmol/l) 1.05 (0.38–2.86) 1.34 (0.45–4.01) 1.53 (0.50–4.71) 
    Triglycerides (mmol/l) 1.09 (0.91–1.30) 1.09 (0.90–1.33) 1.06 (0.91–1.23) 
    Fasting serum glucose (mmol/l)§ 1.09 (0.88–1.36) 1.10 (0.88–1.36) 1.06 (0.85–1.33) 
CrudeAdjusted for age and sexAdjusted for age, sex, and severity of coronary artery disease*
Metabolic syndrome 1.3 (0.7–2.1) 1.3 (0.8–2.3) 1.2 (0.7–2.0) 
Number of components    
    Zero Reference Reference Reference 
    One 0.9 (0.3–3.2) 0.9 (0.3–3.1) 1.1 (0.3–4.1) 
    Two 1.0 (0.3–3.5) 1.0 (0.3–3.5) 1.2 (0.3–4.1) 
    Three 1.4 (0.4–4.7) 1.4 (0.4–4.8) 1.5 (0.4–5.3) 
    Four 1.3 (0.4–4.8) 1.4 (0.4–5.1) 1.3 (0.3–4.9) 
    Five 0.9 (0.2–3.7) 1.0 (0.2–4.0) 1.0 (0.2–4.3) 
Individual components    
    Waist circumference (cm) 1.02 (0.99–1.06) 1.02 (0.99–1.06) 1.02 (0.98–1.06) 
    Systolic blood pressure (mmHg) 0.99 (0.98–1.01) 0.99 (0.97–1.01) 0.99 (0.97–1.01) 
    Diastolic blood pressure (mmHg) 0.98 (0.94–1.01) 0.98 (0.94–1.01) 0.98 (0.94–1.01) 
    HDL cholesterol (mmol/l) 1.05 (0.38–2.86) 1.34 (0.45–4.01) 1.53 (0.50–4.71) 
    Triglycerides (mmol/l) 1.09 (0.91–1.30) 1.09 (0.90–1.33) 1.06 (0.91–1.23) 
    Fasting serum glucose (mmol/l)§ 1.09 (0.88–1.36) 1.10 (0.88–1.36) 1.06 (0.85–1.33) 

Data are OR (95% CI).

*

According to pre-PTCA angiograms (single- versus multivessel disease);

continuously;

patients with antihypertensive drugs excluded from analyses;

§

patients on glucose-lowering agents excluded from analyses.

Close Modal

or Create an Account

Close Modal
Close Modal